Clearmind Medicine Inc. (CMND)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
CNSX $
6. 42
+0.13
+2.0846%
Pre Market
$
+0.13 +2.0249% 6. 55
1.22M Market Cap
- P/E Ratio
- Div Yield
5,566 Volume
- Eps
$ 6.29
Previous Close 
Want to track CMND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Clearmind Medicine Inc. (CMND) Statistics
Valuation metrics
Market Cap 1.22M
Enterprise value -9.02M
Trailing P/E (ttm) -0.07
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.1
Enterprise Value/Revenue -
Enterprise Value/EBITDA 1.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.79K
Average volume (90 days) 382.28K
Price summary
52-Week low 5.25
52-Week high 3,840
Beta -
50-Day moving average 3.7
200-Day moving average 1.87
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 5 Oct 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.44%
Return on equity -0.87%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -37.9
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 80.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 4.31%
Book value per share (mrq) 65.48
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
